References
- Beller F. K., Goessner W., Herrschlein H. J. Tissue activator of the fibrinolytic system in placental tissue. Obstet Gynecol 1962; 20: 117
- Bjerre B., Åstedt B. Maternal mortality in Sweden. Acta Obstet Gynecol Scand 1969; 43: 1
- Björkman S. E. A new method for enumeration of platelets. Acta Haematol 1959; 22: 377
- Bonnar J., McNicol G. P., Douglas A. S. The behaviour of the coagulation and fibrinolytic mechanisms in abruptio placentae. J Obstet Gynaec Brit Cwlth 1969; 76: 799
- Carter B. Premature separation of the normally implanted placenta. Obstet Gynecol 1967; 29: 30
- Edgington T. Fibrinogen and fibrin degradation products: their differentiation. Thrombos. Diathes haemorrh 1975; 34: 671
- Ekelund H., Hedner U., Nilsson I. M. Fibrinolysis in newborn. Acta Paediatr Scand 1970; 59: 33
- Fagerhol M. K., Abildgaard U. Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haemat 1970; 7: 10
- Ganrot P. O. Determination of α2-macroglobulin as trypsinprotein esterase. Clin Chem Acta 1966; 14: 493
- Godal H. C., Abildgaard U., Kierulf P. The ethanol test – an indicator of fibrinemia. Coagulation 1971; 3: 343
- Gustavii B. För tidig placentarlösning. Nordisk Medicin 1969; 82: 1340
- Holmberg L., Nilsson I. M. Genetic variants of von Willebrands disease. Brit Med J 1972; 3: 317
- Klimek R., Stanek J. Epsilon-amino-caproic acid in the treatment of abortions. Gin Pol 1975; 46: 747
- Krupp P., Barclay D., Roeling W., Wegener G. Maternal mortality. Obstet Gynecol 1970; 35: 823
- Niléhn J. E. Influence of split products of fibrinogen on results of blood coagulation tests and platelet adhesiveness. Scand J Haemet 1967; 4: 430
- Nilsson I. M., Blombäck B., Franken I. On an inherited autosomal haemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159: 35
- Nilsson I. M., Olow B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1962; 123: 247
- Nilsson I. M., Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thrombos Diathes Haemorrh 1962; 8: 297
- Owren P. A., Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 3: 201
- Pfleiderer A., Teufel G. Vorzeitige Plazenta-ablösung, Placenta accreta und increta aus klinischer Sicht. Clinical aspects of premature detachment of the placenta, placenta accreta und placenta increta. Verh Dtsch Gest Path 1976; 60: 400
- Pritchard J. Haemotological problems associated with delivery, placental abruption, retained dead fetus and amniotic fluid embolism. Clinics in Haematology 1973; 2: 563
- Sher G. Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy. Am J Obstet Gynecol 1977; 129: 164
- Wardle E. N. Inhibition of fibrinolysis and abruptio placentae. Brit Med J 1978; 1: 1277
- Wolf P. A modification for routine laboratory use of Stefanini's method of estmating factor V activity in human oxalated plasma. J Clin Path 1953; 6: 34
- Åstedt B. Significance of placenta in depression of fibrinolytic activity during pregnancy. J Obstet Gynaec Brit Cwlth 1972; 79: 205
- Åstedt B., Nilsson I. M. Recurrent abruptio placentae treated with the fibrinolytic inhibitor tranexamic acid. Brit Med J 1978; 1: 756